Trichomonas vaginalis
Images: http://www.k-state.edu/parasitology/625tutorials/Protozoa01.html
Phylogeny: Order Trichomonadida
Preferred
definitive host: Humans
Reservoir
hosts: None
Vector/intermediate
host: None
Geographical
location: Cosmopolitan
Organs
Affected: Vagina and
urethra of women and in the
prostate,
seminal vesicles, and
urethra of men
Symptoms
and clinical signs: Frequently
symptomless among males,
but some strains cause inflammation,
with itching and a copious white
discharge swarming with
trichomonads. Vaginal secretions
may become greenish and condition
may become chronic and/or recurrent.
Treatment: Metronidazole
![]()
|
NOTE: To view the article with Web enhancements,
go to:
Trichomoniasis Increases Risk of HIV Infection
Reuters
Health Information 2007. © 2007 Reuters Ltd. This
is one of the first studies to demonstrate a statistically significant link
between Trichomonas vaginalis
and HIV infection, the study team notes. Among
1335 HIV-seronegative female sex workers in According
to Dr. R. Scott McClelland of the A
causal association between vaginal trichomoniasis
and increased risk of HIV infection is biologically plausible, the authors
say, noting that T. vaginalis "leads to an
inflammatory response with recruitment of CD4-bearing lymphocytes and
macrophages to the vaginal and cervical mucosa." Mucosal
hemorrhages can occur with trichomoniasis, which
could provide a physical pathway for HIV-1 infection. Trichomoniasis
may also render women more susceptible to bacterial vaginosis
or persistent abnormal vaginal flora. "Interventions
to prevent and treat trichomoniasis and to improve
vaginal health in general," conclude Dr. McClelland and colleagues,
"could provide important female-controlled methods for reducing the risk
of HIV-1 transmission to women." J Infect Dis 2007;195:698-702. |
Trichomonas
vaginalis increases the
risk of preterm delivery:
